Response to Pokharna and Kanna: initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Garber
A
A
D015986:Confounding Factors, Epidemiologic; D003627:Data Interpretation, Statistical; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D000077154:Rosiglitazone; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use
D004338:Drug Combinations; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; C471074:rosiglitazone-metformin combination; D000077154:Rosiglitazone; D008687:Metformin